The Funding Letter #121: May 3

The Early Bird: Lite Edition 🕊

What is this? The Funding Letter is a daily venture capital newsletter, built for salespeople, by salespeople. Each Letter is sent directly to your inbox hours before Fortune’s Term Sheet, Axios’ Pro Rata, etc, so you’re tipped off before everyone else’s outreach emails flood your Decision-Maker’s inbox.

What’s more? Each announcement is structured so that you get the most important information, immediately. 

THIS IS THE LITE EDITION. For exclusive members only, you’ll get 10+ more funding announcements, in your inbox, first thing in the morning. We’ve also handled C-Suite Breakdowns and Lead Generation, eliminating the manual work of prospecting by delivering 100’s of new leads for you, each week, so you can spend more time selling.

Forwarded this Letter? Apply for your exclusive membership. Get never-before-seen-access to the fastest growing companies of the day, delivered to your inbox for the price of a large cup of coffee each month.

Good morning and happy Friday. This Lite Edition of The Funding Letter comes to you directly from our headquarters in New York City.

Hit the Gong 🎉

Are you an exclusive member with any success stories from using The Funding Letter? Send them by responding to this email for a shoutout in the next issue. Gift cards, gear, and more are on the horizon!

Venture Deals 💸

Want dozens of fresh leads from the companies below? Join the exclusive membership here. Hurry before your competitors swamp their inboxes.

Checkout.com helps companies accept more payments around the world through one integration. View on LinkedIn.

New Funding Raised: $230M, Series A

Round Investors: DST Global (lead), Insight Partners (lead), Blossom Capital, Endeavor Catalyst, GIC

HQ: London, England

Industry: Financial Services

Employee Count: 314

Gossamer Bio is focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. View on LinkedIn.

New Funding Raised: $150M, Post-IPO Debt 

Round Investors: MidCap Financial (lead) 

HQ: San Diego, California

Industry: Biotechnology

Employee Count: 113

Deskera is an award-winning integrated business suite that gives you the freedom to run your business in the cloud. View on LinkedIn.

New Funding Raised: $100M, Series A

Round Investors: Naver Corporation (lead)

HQ: San Francisco, CA

Industry: Computer Software

Employee Count: 201

Indio Technologies simplifies the insurance application process for brokers and their clients. They make it fast, easy, and E&O free. View on LinkedIn.

New Funding Raised: $20M, Series B

Round Investors: Menlo Ventures (lead), 8VC 

HQ: San Francisco, California

Industry: Insurance

Employee Count: 54

CirrusMD is the nation's leading Virtual Care Platform that empowers efficient and more meaningful connections between patients and their healthcare providers. View on LinkedIn.

New Funding Raised: $15M, Series B

Round Investors: Drive Capital (lead), The Colorado Impact Fund

HQ: Denver, Colorado

Industry: Hospital & Health Care

Employee Count: 42

Sense is reinventing the way staffing companies build long-term relationship with this workforce by creating the industry's first engagement platform to provide a "white-glove"​ service to the consultants. View on LinkedIn.

New Funding Raised: $13.5M, Series B

Round Investors: GV (lead), Accel

HQ: San Francisco, California

Industry: Internet 

Employee Count: 283

Confiant protects publishers reputation and revenue with anti-malware software for programmatic buys that keeps you ahead of the bad guys. View on LinkedIn.

New Funding Raised: $4.1M, Series A

Round Investors: River Bay Investments (lead), Rubicon Venture Capital (lead)

HQ: New York, NY

Industry: Computer Software

Employee Count: 31

Free subscribers missed out on early announcements from FreightHub, Dolly, Awair, StartEngine & many more. Want 10+ more announcements delivered to your inbox each day? Subscribe for the exclusive membership below.

Questions? ☎️

If you have an tips, insights, or feedback for how we can improve the Letter, please respond to this email! We use your direct feedback to make immediate, daily updates to the Letter, so we’re all ears.

Would rather take a quick survey (~1 min)? Fill one out here!